USPSTF A & B Recs + Vaccine Schedules Flashcards

Family Medicine (60 cards)

1
Q

Abdominal aortic aneurysm screening

B

A

1-time screening with ultrasonography for men 65-75 who have ever smoked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Anxiety disorder screening in adults

B

A

screening in all adults, including pregnant and postpartum persons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Anxiety disorder screening in children

B

A

screening in children/adolescents 8-18 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Aspirin prevention in preeclampsia

B

A

low-dose aspirin (81mg/day) after 12 weeks gestation in persons at high risk for preeclampsia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Asymptomatic bacteriuria screening

B

A

urine culture screening for all pregnant persons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

BRCA risk assessment tool

A

women with personal/family hx of breast, ovarian, tubal, peritoneal cancer or BRCA1/2 gene mutations: assess risk with familial risk assessment tool

those with positive result should receive genetic counseling and testing if indicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Breast cancer medication use to reduce risk

B

A

in women > 35 years with increased risk for breast cancer + low risk for adverse medication effects, offer risk-reducing medications (tamoxifen, raloxifene, aromatase inhibitors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Breast cancer screening (mammogram)

B

A

biennial screening mammography for women 40-74 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Breastfeeding behavioral counseling interventions

B

A

primary care interventions/referrals for breastfeeding support during pregnancy and after birth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cervical cancer screening (pap smear cervical cytology, HPV testing)

A

A

women 21-29: pap smear alone every 3 years

women 30-65: pap smear alone every 3 years OR HPV testing alone every 5 years OR combined pap + HPV every 5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Chlamydia + gonorrhea screening

B

A

women 24 years or younger: screening in all sexually active women

women 25 years or older: screening in women at increased risk for infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Colorectal cancer screening

A/B

A

adults 45-49 years: B recommendation to screen

adults 50-75 years: A recommendation to screen all adults

patients with first-degree relative with CRC or high risk adenomatous polyp: colonoscopy at 40yo (or 10 years before age of FDR dx), repeat every 5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Depression and suicide risk screening

B

A

Adults: screening for depression in all adults

Children 12-18 years: screening for MDD in adolescents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Fall prevention in community-dwelling older adults

B

A

Adults 65+ years who are at increased risk of falls: exercise interventions recommended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Folic acid supplementation

A

A

All persons planning to or who could become pregnant (not on birth control): take a daily folic acid supplement containing 0.4-0.8 mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Gestational diabetes screening in pregnant persons

B

A

Asymptomatic pregnant persons at 24 weeks or after: recommend screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Behavioral counseling interventions for cardiovascular disease prevention

B

A

Adults with cardiovascular risk factors: offer/refer to behavioral counseling to promote healthy diet and physical activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Behavioral counseling interventions for promoting healthy weight gain in pregnancy

B

A

All pregnant persons should be offered effective behavioral counseling interventions aimed at promoting healthy weight gain and preventing excess gestational weight gain in pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Hep B screening

A/B

A

Adolescents and adults (B): only in those at increased risk for infection (parents from regions with high prevalence of HBV, did not receive vaccine as infants, IVDU, MSM, household contacts of HBsAg positive)

Pregnant women (A): all pregnant women at their first prental visit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hep C screening

B

A

adults 18-79 years: all adults should get screened for HCV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

High BMI interventions in children/adolescents

B

A

children/adolescents 6+ years: those with BMI over 95th percentile should get comprehensive, intensive behavioral interventions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

HIV screening

A

A

adolescents/adults 15-65 years: all should be screened

younger adolescents < 15 and older adults >65: those at increased risk of infx should be screened

pregnant persons: all pregnant persons should be screened, including those present in labor/delivery whose HIV status is unknown

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Hypertension screening

A/B

A

adults 18+ years (A): all adults should be screened with office BP measurement

pregnant persons (B): screening for hypertensive disorders with BP measurements throughout pregnancy

BP measurements outside of the clinical setting should be obtained for diagnostic confirmation before starting tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Abuse screening

B

A

women of reproductive age: screen for IPV and refer those who screen positive to ongoing support services

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Latent TB screening ## Footnote B
Asymptomatic adults at increased risk should get screening - born in/former residents of countries with high TB prevalence - live(d) in high-risk congregate settings (homeless shelters, correctional facilities) - immunosuppression - contacts of individuals with active TB, healthcare workers, workers in high-risk congregate settings
26
Lung cancer screening ## Footnote B
Adults 50-80 years who have a 20 pack-year smoking hx and currently smoke or have quit within the past 15 years Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery
27
Ocular prophylaxis for gonococcal ophthalmia | A
All newborns should receive prophylactic ocular topical medication to prevent gonococcal ophthalmia neonatorum
28
Osteoporosis screening ## Footnote B
postmenopausal women < 65 years at increased risk for osteoporotic fracture - cigarette smoking, excess alcohol consumption, low body weight, parental hx of hip fracture - corticosteroids, insulin all women > 65 years
29
Perinatal depression preventive interventions ## Footnote B
pregnant/postpartum persons at increased risk of perinatal depression: refer to counseling interventions - unplanned pregnancy, hx of depression, hx of physical/sexual abuse, stressful life events, gestational diabetes, complications during pregnancy - low socioeconomic status, lack of social/financial support, adolescent parenthood
30
Prediabetes and T2DM screening ## Footnote B
adults 35-70 years who are overweight/obese: screening for prediabetes/T2DM if prediabetic, offer/refer effective preventive interventions
31
HIV preexposure prophylaxis ## Footnote A
all persons at increased risk of HIV acquisition: prescribe preexposure prophylaxis - needle sharing injection drug use - condomless receptive anal intercourse - partner with HIV, MSM with STI in past 6mo, history of inconsistent condom use
32
Prevention of dental caries ## Footnote B
fluoride varnish: all infants/children starting at age of primary tooth eruption oral fluoride supplementation: 6 months+ for children whose water supply is deficient in fluoride
33
Rh(D) incompatibility screening ## Footnote A/B
all pregnant women during first visit: Rh(D) blood typing and antibody testing unsensitized Rh(D) negative pregnant women: repeated Rh(D) antibody testing at 24-28 weeks gestation, unless father is known to be Rh(D) neg
34
STI behavioral counseling ## Footnote B
all sexually active adolescents + adults who are at increased risk for STIs
35
Skin cancer prevention, behavioral counseling ## Footnote B
6 months - 24 years with fair skin types: counseling about minimizing exposure to UV radiation
36
Statin use for primary prevention of CVD ## Footnote B
adults 40-75 years who have 1+ CVD risk factors (dyslipidemia, diabetes, HTN, smoking), 10-year CVD risk of >10%
37
Syphilis infection screening ## Footnote A
all adolescents/adults at increased risk for syphilis infection early screening for syphilis in all pregnant women
38
Tobacco smoking cessation interventions ## Footnote A
all adults (including pregnant people): ask about tobacco use, advise to stop using tobacco, provide behavioral interventions all adults minus pregnant people: offer FDA-approved pharmacotherapy as well school-aged children who have not started to use tobacco: education + brief counseling to prevent initiation
39
Unhealthy alcohol use screening + behavioral counseling interventions ## Footnote B
adults 18+ years: screen for unhealthy alcohol use, provide those engaged in risky drinking with brief behavioral counseling interventions
40
Unhealthy drug use screening ## Footnote B
adults 18+ years: ask screening questions about unhealthy drug use when services for dx/tx/care can be offered
41
Vision screening ## Footnote B
children 3 - 5 years: vision screening at least once to detect amblyopia (lazy eye) or its risk factors
42
Weight loss to prevent obesity-related morbidity ## Footnote B
adults with BMI of 30+: offer or refer intensive multicomponent behavioral interventions
43
Respiratory syncytial virus (RSV) vaccine (nirsevimab) ## Footnote for infants
infants whose mother did not receive RSV vaccine or received RSV vaccine < 14 days prior to delivery: 1 dose shortly after birth (or shortly before start of RSV season) all babies: 1 dose between 8-19 months
44
RSV vaccine (Abrysvo) ## Footnote for adults
pregnant at 32-36 weeks from Sept through Jan: 1 dose Abrysvo all other pregnant women: RSV vaccine not recommended subsequent pregnancies: additional doses not recommended
45
Hep B vaccine
3 dose series: 1st at birth 2nd between 1-2mo 3rd between 6-18mo
46
Rotavirus vaccine
2 or 3 dose series, depending on brand: 1st at 2mo 2nd at 4mo 3rd (only for RotaTeq) at 6mo catch up dose: max age is 8mo
47
Diphtheria, tetanus, acellular pertussis (DTaP) vaccine
5 dose series (3 dose primary, 2 boosters): 1st at 2mo 2nd at 4mo 3rd at 6mo 4th between 12-18mo 5th between 4-6 years
48
Tetanus, diphtheria, acellular pertussis (Tdap) vaccine
1 dose adolescent booster between 11-12 years 1 dose Tdap in pregnancy in weeks 27-36 (to protect against pertussis)
49
H. influenzae type B (Hib) vaccine
3 or 4 dose series: 1st at 2mo 2nd at 4mo 3rd at 6mo (only in 4 dose series) 4th between 12-15mo
50
Pneumococcal conjugate vaccine (PCV)
4 dose series: 1st at 2mo 2nd at 4mo 3rd at 6mo 4th between 12-15mo
51
Inactivated poliovirus (IPV) vaccine
4 dose series: 1st at 2mo 2nd at 4mo 3rd between 6-18mo 4th between 4-6 years
52
Influenza vaccine
1-2 doses annually
53
Measles, mumps, rubella (MMR) vaccine
2 dose series: 1st between 12-15mo 2nd between 4-6 years children 12-47mo: recommended to administer MMR and varicella vaccines separately
54
Varicella vaccine
2 dose series: 1st between 12-15mo 2nd between 4-6 years children 12-47mo: recommended to administer MMR and varicella vaccines separately
55
Hep A vaccine
2 dose series: between 12-23 months, spaced out with at least 6mo in between
56
Human papillomavirus (HPV) vaccine
minimum age 9, routinely recommended at age 11-12 years 2 or 3 dose series depending on age at initial vaccination: - age 9-14 at initial: 2 dose series at 0, 6-12 months - age 15+ at initial: 3 dose series at 0, 1-2 months, 6 months
57
Meningococcal serogroup A,C,W,Y vaccine
2 dose series: 1st at 11-12 years 2nd at 16 years
58
Meningococcal serogroup B vaccine
use shared clinical decision making for adolescents age 16-23 who are not at increased risk 2 or 3 dose series
59
Dengue vaccine
age 9-16 years living in areas with endemic dengue AND have lab confirmation of previous dengue infection 3 dose series: 0, 6, 12 months
60
Mpox vaccine
age 18+ with increased risk for infection (gay, bisexual, MSM with new STI dx, more than 1 partner, etc) 2 dose series: 28 days apart